Along with gaining insights into how to tap into the expertise of cord blood banks and access therapy-matched cord blood units (CBUs), you’ll get a better understanding of:

  • Comprehensive benefits of cord blood as an allogeneic cell source for cellular therapy
  • Characteristics and attributes of the existing cord blood inventory
  • Importance of managing logistics for delivery of CBUs from the bank to the cell therapy developer
  • Alternative banking and attribute models that may be needed in the future to support novel therapies 


Heather Stefanski, MD, PhD
Vice President of Medical Services

Marcie Finney, MBA 
Executive Director
Cleveland Cord Blood Center

Christina Melief, PhD
Senior Scientific Program Advisor

Ana Valverde, MBA
Administrative Director
Carolinas Cord Blood Bank